Dose–response relationships of normal blood lipid levels in metabolic and endocrine diseases: mechanistic similarities, differences, and functional insights - Report - MDSpire
Advertisement
Dose–response relationships of normal blood lipid levels in metabolic and endocrine diseases: mechanistic similarities, differences, and functional insights
Dose-Response Associations of Normal Blood Lipid Levels in Metabolic and Endocrine Disorders
Overview
This review highlights that variations in blood lipid levels within the clinically defined normal range can still influence the risk of metabolic and endocrine diseases through complex dose–response relationships. It emphasizes the dual physiological and pathological roles of major lipid components and the need for refined risk assessment beyond traditional lipid targets.
Background
Blood lipids are crucial for energy homeostasis, cellular structure, and endocrine signaling regulation. While hyperlipidemia is a recognized risk factor for metabolic and endocrine disorders, subtle fluctuations within normal lipid ranges may also contribute to disease risk. Traditional binary classifications of lipid levels as 'normal' or 'abnormal' may overlook continuous dose–response effects that influence early pathological processes such as insulin resistance and atherosclerosis.
Data Highlights
Lipid Component
Physiological Role
Pathological Role
HDL-C
Vasoprotection via reverse cholesterol transport and anti-inflammatory effects
Structural remodeling and pro-inflammatory phenotype in chronic inflammation and diabetes
LDL-C
Cholesterol delivery for membrane integrity and steroid hormone synthesis
Oxidative modification leading to vascular inflammation and atherosclerosis
Triglycerides (TG)
Primary energy storage and fatty acid source
Associated with insulin resistance, metabolic syndrome, cardiovascular disease, and acute pancreatitis when elevated
Total Cholesterol (TC)
Regulates membrane fluidity and precursor of bioactive molecules
Imbalance increases cardiovascular disease risk
Key Findings
Blood lipid components have dual roles: physiological maintenance and potential pathological injury depending on context.
Even lipid levels within the normal reference range show dose–response relationships with metabolic and endocrine disease risk.
HDL-C can lose protective functions and become pro-inflammatory in chronic disease states.
LDL-C accumulation and oxidative modification are key initiators of vascular inflammation and atherosclerosis.
Triglycerides are linked to insulin resistance and cardiovascular risk even at normal levels.
Traditional static lipid reference values may not fully capture individual metabolic risk profiles.
Clinical Implications
Clinicians should consider that lipid levels within the normal range may still confer varying degrees of metabolic and endocrine risk. Risk assessment strategies should move beyond fixed lipid targets to incorporate dose–response relationships and individual patient contexts. This approach may facilitate earlier identification of at-risk individuals and enable personalized lifestyle and therapeutic interventions.
Conclusion
Subtle fluctuations in blood lipid levels within the normal range have complex and heterogeneous effects on metabolic and endocrine disease risk. Future research and clinical practice should adopt refined, individualized lipid risk assessments to improve early detection and management of these disorders.
References
Author/Source/Year -- Exploring Dose-Response Associations of Normal Blood Lipid Levels in Metabolic and Endocrine Disorders: Mechanistic Insights and Variations
